Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.91
1.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

Immunic Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 114K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
43K 43K 57K 42K 31K 26K 23K 34K 22K 32K 19K 17K 20K 21K 40K 16K 15K 14K
Gross Profit
-43K -43K 57K -42K -31K -26K -23K -34K -22K -32K -19K -17K -20K -21K -40K -16K -15K -14K
Operating Income
-27.08M -26.82M -25.63M -25.73M -22.81M -23.88M -23.38M -23.57M -25.02M -27.25M -57.33M -20.12M -20.61M -21.43M -21.72M -18.39M -19.17M -32.39M
Interest Income
241K 183K 429K 776K 998K 1.19M 541K 766K 968K 800K 698K 230K 106K 7K 15K 10K 13K 28K
Pretax Income
-26.82M -25.47M -25.18M -24.37M -21.38M -29.58M -21.57M -22.77M -24M -25.27M -56.47M -21.22M -21.9M -20.81M -21.18M -19.29M -17.93M -34.53M
Net Income
-26.82M -25.47M -25.18M -24.37M -21.38M -29.58M -21.57M -22.77M -24M -23.26M -88.59M -22.33M -21.9M -20.18M -21.18M -19.29M -17.93M -34.53M
Selling & General & Admin
5.71M 5.29M 4.01M 4.36M 4.46M 5.12M 4.1M 3.77M 3.85M 4.29M 3.62M 3.58M 4.07M 3.99M 3.34M 2.91M 3.43M 20.87M
Research & Development
21.37M 21.53M 21.62M 21.37M 18.32M 18.74M 19.28M 19.8M 21.17M 22.96M 20.73M 16.54M 16.54M 17.45M 18.38M 15.48M 15.74M 11.52M
Other Expenses
n/a n/a -35K n/a n/a n/a -23K n/a 54K n/a 155K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
27.08M 26.82M 25.6M 25.73M 22.78M 23.86M 23.36M 23.57M 25.02M 27.25M 24.36M 20.12M 20.61M 21.43M 21.72M 18.39M 19.17M 32.39M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -31K -26K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.08M 26.82M 25.63M 25.73M 22.81M 23.88M 23.38M 23.57M 25.02M 27.25M 24.36M 20.12M 20.61M 21.43M 21.72M 18.39M 19.17M 32.39M
Income Tax Expense
n/a n/a n/a n/a n/a -17.28K n/a n/a n/a -2.01M 32.12M 1.11M -126K -627K -55K -10K -13K -28K
Shares Outstanding (Basic)
132.18M 101.34M 90.15M 101.27M 101.27M 97.3M 44.63M 44.57M 44.43M 43.66M 31.82M 30.56M 30.25M 28.13M 25.32M 25.32M 21.75M 21.17M
Shares Outstanding (Diluted)
132.18M 101.34M 90.15M 101.27M 101.27M 97.3M 44.63M 44.57M 44.43M 43.66M 31.82M 30.56M 30.25M 28.13M 25.32M 25.32M 21.75M 21.17M
EPS (Basic)
-0.2 -0.25 -0.28 -0.24 -0.21 -0.3 -0.48 -0.51 -0.54 -0.53 -2.78 -0.73 -0.72 -0.72 -0.84 -0.76 -0.82 -1.63
EPS (Diluted)
-0.2 -0.25 -0.28 -0.24 -0.21 -0.3 -0.48 -0.51 -0.54 -0.53 -2.78 -0.73 -0.72 -0.72 -0.84 -0.76 -0.82 -1.63
EBITDA
-26.78M -26.82M -25.6M -25.68M -22.78M -23.86M -23.36M -23.54M -25M -27.22M -24.34M -20.1M -20.59M -21.41M -21.68M -18.37M -19.16M -34.52M
EBIT
-26.82M -25.47M -25.63M -25.73M -22.81M -23.88M -23.38M -23.57M -25.02M -27.25M -24.36M -20.12M -20.61M -21.43M -21.72M -18.39M -19.17M -34.53M
Depreciation & Amortization
43K 43K 35K 42K 31K 26K 23K 34K 22K 32K 19K 17K 20K 21K 40K 16K 15K 14K